{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:26:49Z","timestamp":1786991209646,"version":"build-2736575974"},"reference-count":59,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000646","name":"JSPS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000646","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Allergology International"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.alit.2025.05.004","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T07:52:27Z","timestamp":1749196347000},"page":"52-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical utility of YKL-40 for understanding pathophysiology of obstructive airway disorders"],"prefix":"10.1016","volume":"75","author":[{"given":"Yasuhito","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junpei","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suguru","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuro","family":"Fukuhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mami","family":"Rikimaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikaru","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Kazama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koshi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Harigane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riko","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuki","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsumi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Umeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuichi","family":"Togawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Minemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takefumi","family":"Nikaido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenya","family":"Kanazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xintao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Tanino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.alit.2025.05.004_bib1","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0140-6736(22)02125-0","article-title":"Asthma","volume":"401","author":"Porsbjerg","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.alit.2025.05.004_bib2","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S0140-6736(17)32136-0","article-title":"What does endotyping mean for treatment in chronic obstructive pulmonary disease?","volume":"390","author":"Agust\u00ed","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.alit.2025.05.004_bib3","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1183\/09031936.06.00072105","article-title":"Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment","volume":"27","author":"Leigh","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.alit.2025.05.004_bib4","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.2147\/COPD.S167600","article-title":"Clinical utility of fractional exhaled nitric oxide and blood eosinophils counts in the diagnosis of asthma-COPD overlap","volume":"13","author":"Takayama","year":"2018","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.alit.2025.05.004_bib5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1006\/geno.1997.4778","article-title":"Molecular characterization of the gene for human cartilage gp-39 (CHI3L1), a member of the chitinase protein family and marker for late stages of macrophage differentiation","volume":"43","author":"Rehli","year":"1997","journal-title":"Genomics"},{"key":"10.1016\/j.alit.2025.05.004_bib6","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/ACI.0b013e3283306533","article-title":"The chitinase and chitinase-like proteins: a review of genetic and functional studies in asthma and immune-mediated diseases","volume":"9","author":"Ober","year":"2009","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2025.05.004_bib7","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1046\/j.1432-1327.1998.2510504.x","article-title":"Chitotriosidase, a chitinase, and the 39-kDa human cartilage glycoprotein, a chitin-binding lectin, are homologues of family 18 glycosyl hydrolases secreted by human macrophages","volume":"251","author":"Renkema","year":"1998","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.alit.2025.05.004_bib8","first-page":"351","article-title":"YKL-40, a mammalian member of the chitinase family, is a matrix protein of specific granules in human neutrophils","volume":"110","author":"Volck","year":"1998","journal-title":"Proc Assoc Am Physicians"},{"key":"10.1016\/j.alit.2025.05.004_bib9","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1006\/excr.1999.4511","article-title":"Gp38k, a protein synthesized by vascular smooth muscle cells, stimulates directional migration of human umbilical vein endothelial cells","volume":"250","author":"Malinda","year":"1999","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.alit.2025.05.004_bib10","doi-asserted-by":"crossref","first-page":"29817","DOI":"10.1074\/jbc.M110.103416","article-title":"The chitinase-like protein YKL-40 is secreted by airway epithelial cells at base line and in response to compressive mechanical stress","volume":"285","author":"Park","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.alit.2025.05.004_bib11","doi-asserted-by":"crossref","first-page":"438","DOI":"10.4049\/jimmunol.1201827","article-title":"YKL-40 induces IL-8 expression from bronchial epithelium via MAPK (JNK and ERK) and NF-kappaB pathways, causing bronchial smooth muscle proliferation and migration","volume":"190","author":"Tang","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.alit.2025.05.004_bib12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12931-018-0755-6","article-title":"Plasma YKL-40 and NGAL are useful in distinguishing ACO from asthma and COPD","volume":"19","author":"Wang","year":"2018","journal-title":"Respir Res"},{"key":"10.1016\/j.alit.2025.05.004_bib13","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.alit.2017.02.010","article-title":"Utility of serum YKL-40 levels for identification of patients with asthma and COPD","volume":"66","author":"Gon","year":"2017","journal-title":"Allergol Int"},{"key":"10.1016\/j.alit.2025.05.004_bib14","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1056\/NEJMoa073600","article-title":"A chitinase-like protein in the lung and circulation of patients with severe asthma","volume":"357","author":"Chupp","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.alit.2025.05.004_bib15","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.4049\/jimmunol.181.7.5167","article-title":"YKL-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages","volume":"181","author":"Letuve","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.alit.2025.05.004_bib16","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1159\/000330840","article-title":"Sputum YKL-40 levels and pathophysiology of asthma and chronic obstructive pulmonary disease","volume":"83","author":"Otsuka","year":"2012","journal-title":"Respiration"},{"key":"10.1016\/j.alit.2025.05.004_bib17","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.2147\/COPD.S113484","article-title":"Characterization of sputum biomarkers for asthma-COPD overlap syndrome","volume":"11","author":"Gao","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.alit.2025.05.004_bib18","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1164\/rccm.201504-0760OC","article-title":"Increased YKL-40 and chitotriosidase in asthma and chronic obstructive pulmonary disease","volume":"193","author":"James","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.alit.2025.05.004_bib19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jaci.2015.11.020","article-title":"Multidimensional endotyping in patients with severe asthma reveals inflammatory heterogeneity in matrix metalloproteinases and chitinase 3-like protein 1","volume":"138","author":"Hinks","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2025.05.004_bib20","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.2147\/COPD.S184097","article-title":"Overexpression of chitotriosidase and YKL-40 in peripheral blood and sputum of healthy smokers and patients with chronic obstructive pulmonary disease","volume":"14","author":"Majewski","year":"2019","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.alit.2025.05.004_bib23","series-title":"The JRS Guidelines for the Management of ACO","year":"2023"},{"key":"10.1016\/j.alit.2025.05.004_bib24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1378\/chest.15-1055","article-title":"Defining the asthma-COPD overlap syndrome in a COPD cohort","volume":"149","author":"Cosio","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.alit.2025.05.004_bib25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaci.2003.09.008","article-title":"Development of the asthma control test: a survey for assessing asthma control","volume":"113","author":"Nathan","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2025.05.004_bib26","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1183\/09031936.00102509","article-title":"Development and first validation of the COPD assessment test","volume":"34","author":"Jones","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.alit.2025.05.004_bib27","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/thx.54.7.581","article-title":"Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease","volume":"54","author":"Bestall","year":"1999","journal-title":"Thorax"},{"key":"10.1016\/j.alit.2025.05.004_bib28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1164\/rccm.200801-060ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice","volume":"180","author":"Reddel","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.alit.2025.05.004_bib29","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1164\/rccm.202108-1819PP","article-title":"An updated definition and severity classification of chronic obstructive pulmonary disease exacerbations: the Rome proposal","volume":"204","author":"Celli","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"2 Pt 1","key":"10.1016\/j.alit.2025.05.004_bib30","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1164\/ajrccm.154.2.8756799","article-title":"Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements","volume":"154","author":"Pizzichini","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.alit.2025.05.004_bib31","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/00365510050184886","article-title":"Stability of YKL-40 concentration in blood samples","volume":"60","author":"H\u00f8gdall","year":"2000","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.alit.2025.05.004_bib32","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.alit.2025.05.004_bib33","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1164\/rccm.200406-710ST","article-title":"ATS\/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005","volume":"171","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.alit.2025.05.004_bib34","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2147\/COPD.S97343","article-title":"COPD assessment test and severity of airflow limitation in patients with asthma, COPD, and asthma-COPD overlap syndrome","volume":"11","author":"Kurashima","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.alit.2025.05.004_bib35","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1164\/rccm.202206-1041ST","article-title":"Syndrome of combined pulmonary fibrosis and emphysema: an official ATS\/ERS\/JRS\/ALAT Research statement","volume":"206","author":"Cottin","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.alit.2025.05.004_bib36","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jaip.2018.06.015","article-title":"Combined assessment of serum periostin and YKL-40 may identify asthma-COPD overlap","volume":"7","author":"Shirai","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.alit.2025.05.004_bib37","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S2213-2600(15)00367-7","article-title":"Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study","volume":"3","author":"Price","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.alit.2025.05.004_bib38","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S2213-2600(16)00100-4","article-title":"Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial","volume":"4","author":"Watz","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.alit.2025.05.004_bib39","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jaci.2013.06.007","article-title":"Exhaled nitric oxide levels and blood eosinophil counts independently associate with wheeze and asthma events in National Health and Nutrition Examination Survey subjects","volume":"132","author":"Malinovschi","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2025.05.004_bib40","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01457-2017","article-title":"Persistently elevated exhaled nitric oxide fraction is associated with increased risk of exacerbation in COPD","volume":"51","author":"Alc\u00e1zar-Navarrete","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.alit.2025.05.004_bib41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1164\/rccm.200901-0047OC","article-title":"The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort","volume":"180","author":"Kohansal","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.alit.2025.05.004_bib42","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jaci.2005.06.028","article-title":"Chitinases and chitinase-like proteins in T(H)2 inflammation and asthma","volume":"116","author":"Elias","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2025.05.004_bib43","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1084\/jem.20081271","article-title":"Role of breast regression protein 39 (BRP-39)\/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis","volume":"206","author":"Lee","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.alit.2025.05.004_bib44","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12931-019-1051-9","article-title":"Chitinase-like protein YKL-40 correlates with inflammatory phenotypes, anti-asthma responsiveness and future exacerbations","volume":"20","author":"Liu","year":"2019","journal-title":"Respir Res"},{"key":"10.1016\/j.alit.2025.05.004_bib45","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1515\/folmed-2017-0013","article-title":"YKL-40 and cytokines - a new diagnostic constellation in rheumatoid arthritis?","volume":"59","author":"Kazakova","year":"2017","journal-title":"Folia Med (Plovdiv)"},{"key":"10.1016\/j.alit.2025.05.004_bib46","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12931-016-0338-3","article-title":"YKL-40 expression in chronic obstructive pulmonary disease: relation to acute exacerbations and airway remodeling","volume":"17","author":"Lai","year":"2016","journal-title":"Respir Res"},{"key":"10.1016\/j.alit.2025.05.004_bib47","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1620\/tjem.229.163","article-title":"High serum YKL-40 level in patients with COPD is related to hypoxemia and disease severity","volume":"229","author":"Gumus","year":"2013","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.alit.2025.05.004_bib48","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/j.rmed.2013.07.013","article-title":"The relation of circulating YKL-40 to levels and decline of lung function in adult life","volume":"107","author":"Guerra","year":"2013","journal-title":"Respir Med"},{"key":"10.1016\/j.alit.2025.05.004_bib49","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1016\/j.jaip.2019.03.043","article-title":"YKL-40 and adult-onset asthma: elevated levels in clusters with poorest outcome","volume":"7","author":"Ilmarinen","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.alit.2025.05.004_bib50","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00800-2017","article-title":"Characterisation of asthma subgroups associated with circulating YKL-40 levels","volume":"50","author":"Gomez","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.alit.2025.05.004_bib51","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.anai.2022.03.016","article-title":"Further evidence for association of YKL-40 with severe asthma airway remodeling","volume":"128","author":"Kimura","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.alit.2025.05.004_bib52","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2147\/COPD.S152655","article-title":"The YKL-40 protein is a potential biomarker for COPD: a meta-analysis and systematic review","volume":"13","author":"Tong","year":"2018","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.alit.2025.05.004_bib53","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1378\/chest.126.1.59","article-title":"Asthma as a risk factor for COPD in a longitudinal study","volume":"126","author":"Silva","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.alit.2025.05.004_bib54","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1164\/rccm.200712-1869OC","article-title":"Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study","volume":"178","author":"Celli","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.alit.2025.05.004_bib55","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2500\/ajra.2013.27.3941","article-title":"Increased expression of YKL-40 in mild and moderate\/severe persistent allergic rhinitis and its possible contribution to remodeling of nasal mucosa","volume":"27","author":"Park","year":"2013","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.alit.2025.05.004_bib56","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.cca.2011.01.022","article-title":"Plasma YKL-40 levels in healthy subjects from the general population","volume":"412","author":"Bojesen","year":"2011","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.alit.2025.05.004_bib57","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1080\/10408363.2016.1190683","article-title":"Role of inflammatory marker YKL-40 in the diagnosis, prognosis and cause of cardiovascular and liver diseases","volume":"53","author":"Kjaergaard","year":"2016","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.alit.2025.05.004_bib58","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1097\/MPA.0b013e31824d9b93","article-title":"Increased levels of YKL-40 and interleukin 6 in patients with chronic pancreatitis and secondary diabetes","volume":"41","author":"Hansen","year":"2012","journal-title":"Pancreas"},{"key":"10.1016\/j.alit.2025.05.004_bib59","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12931-023-02394-6","article-title":"Chronic Airways Assessment Test: psychometric properties in patients with asthma and\/or COPD","volume":"24","author":"Tomaszewski","year":"2023","journal-title":"Respir Res"},{"key":"10.1016\/j.alit.2025.05.004_bib60","doi-asserted-by":"crossref","first-page":"194","DOI":"10.5152\/ThoracResPract.2023.22198","article-title":"Validity and reliability of the Turkish version of the Nijmegen questionnaire in asthma","volume":"24","author":"\u00c7akmak","year":"2023","journal-title":"Thorac Res Pract"},{"key":"10.1016\/j.alit.2025.05.004_bib61","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.jaip.2023.12.021","article-title":"Burden of uncontrolled severe asthma with and without elevated type-2 inflammatory biomarkers","volume":"12","author":"Ding","year":"2024","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["Allergology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893025000541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893025000541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T09:56:02Z","timestamp":1768557362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1323893025000541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1323893025000541"],"URL":"https:\/\/doi.org\/10.1016\/j.alit.2025.05.004","relation":{},"ISSN":["1323-8930"],"issn-type":[{"value":"1323-8930","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical utility of YKL-40 for understanding pathophysiology of obstructive airway disorders","name":"articletitle","label":"Article Title"},{"value":"Allergology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.alit.2025.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Japanese Society of Allergology. Published by Elsevier B.V\u00e9","name":"copyright","label":"Copyright"}]}}